Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b. / Goodin, Douglas; Reder, Anthony; Traboulsee, Anthony; Li, David; Langdon, Dawn; Cutter, Gary; Cook, Stuart ; O'Donnell, Timothy; Kremenchutzky, Marcelo; Oger, Joel; Koelbach, Ralf; Pohl, Christoph; Wicklein, Eva-Maria.

In: Multiple Sclerosis Journal, 15.05.2018, p. 1-11.

Research output: Contribution to journalArticlepeer-review

E-pub ahead of print


  • Douglas Goodin
  • Anthony Reder
  • Anthony Traboulsee
  • David Li
  • Dawn Langdon
  • Gary Cutter
  • Stuart Cook
  • Timothy O'Donnell
  • Marcelo Kremenchutzky
  • Joel Oger
  • Ralf Koelbach
  • Christoph Pohl
  • Eva-Maria Wicklein
Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalMultiple Sclerosis Journal
Early online date15 May 2018
Publication statusE-pub ahead of print - 15 May 2018
This open access research output is licenced under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

ID: 29849677